BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Green MV, Thayer SA. HIV gp120 upregulates tonic inhibition through α5-containing GABAARs. Neuropharmacology 2019;149:161-8. [PMID: 30797029 DOI: 10.1016/j.neuropharm.2019.02.024] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Tian H, He B, Yin Y, Liu L, Shi J, Hu L, Jiang G. Chemical Nature of Metals and Metal-Based Materials in Inactivation of Viruses. Nanomaterials (Basel) 2022;12:2345. [PMID: 35889570 DOI: 10.3390/nano12142345] [Reference Citation Analysis]
2 Irollo E, Luchetta J, Ho C, Nash B, Meucci O. Mechanisms of neuronal dysfunction in HIV-associated neurocognitive disorders. Cell Mol Life Sci 2021;78:4283-303. [PMID: 33585975 DOI: 10.1007/s00018-021-03785-y] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 12.0] [Reference Citation Analysis]
3 Crocetti L, Guerrini G. GABAA receptor subtype modulators in medicinal chemistry: an updated patent review (2014-present). Expert Opin Ther Pat 2020;30:409-32. [PMID: 32200689 DOI: 10.1080/13543776.2020.1746764] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
4 Nash B, Festa L, Lin C, Meucci O. Opioid and chemokine regulation of cortical synaptodendritic damage in HIV-associated neurocognitive disorders. Brain Res 2019;1723:146409. [PMID: 31465771 DOI: 10.1016/j.brainres.2019.146409] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]